Mallinckrodt PLC resigned from the Pharmaceutical Research and Manufacturers Association on Monday ahead of potential changes to the trade group’s by-laws that could exclude companies that don’t spend significant funds on researching and developing new drugs.
from WSJ.com: US Business http://ift.tt/2p1yeEe
via IFTTT
No comments:
Post a Comment